Equine Infectious Anemia Virus and Human Immunodeficiency Virus DNA Synthesis in Vitro: Characterization of the Endogenous Reverse Transcriptase Reaction
Overview
Authors
Affiliations
The endogenous reverse transcriptase reaction of equine infectious anemia virus (EIAV) has been studied, and conditions allowing synthesis of full-length minus-strand DNA have been determined. In contrast to results reported for other retroviruses, synthesis of EIAV full-length minus-strand DNA was not impaired by high concentrations of Nonidet P-40, a nonionic detergent used to make the virion envelope permeable. All components of the reaction were titrated for maximum synthesis of complete minus strands, and a time course under the standardized conditions was determined. Minor subgenomic bands were observed in some cases, and both the size and proportion varied with reaction conditions. Conditions established for full-length EIAV DNA synthesis also allowed full-genome-length human immunodeficiency virus type 1 DNA synthesis. The human immunodeficiency virus type 1 DNA product contained a greater proportion of reverse transcripts that were shorter than the complete virus genome. Also in contrast to EIAV, the endogenous synthesis of high-molecular-weight human immunodeficiency virus type 1 DNA was drastically reduced at Nonidet P-40 concentrations above 0.02%. These results indicated that a detergent-stable core is not a property shared by all lentiviruses. The EIAV virion synthetic machinery is unusually stable and provides a convenient system for further in vitro study of reverse transcription.
Jennings J, Shi J, Varadarajan J, Jamieson P, Aiken C mBio. 2020; 11(6).
PMID: 33262260 PMC: 7733946. DOI: 10.1128/mBio.02820-20.
Genomic flexibility of human endogenous retrovirus type K.
Dube D, Contreras-Galindo R, He S, King S, Gonzalez-Hernandez M, Gitlin S J Virol. 2014; 88(17):9673-82.
PMID: 24920813 PMC: 4136327. DOI: 10.1128/JVI.01147-14.
Implications of the nucleocapsid and the microenvironment in retroviral reverse transcription.
Mougel M, Cimarelli A, Darlix J Viruses. 2011; 2(4):939-960.
PMID: 21994662 PMC: 3185662. DOI: 10.3390/v2040939.
Arhel N Retrovirology. 2010; 7:96.
PMID: 21083892 PMC: 2998454. DOI: 10.1186/1742-4690-7-96.
Warrilow D, Warren K, Harrich D PLoS One. 2010; 5(10):e13229.
PMID: 20949087 PMC: 2950853. DOI: 10.1371/journal.pone.0013229.